NBIX同业对比
NBIX 与iShares Biotechnology ETF 持仓的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:IBB 前十大持仓| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NBIX本股 | $15.3B#14 | 21.9x#3 | 4.1x#2 | 5.3x#3 | 21.4%#6 | 40.2%#9 | 21.6%#8 | 13.0%#8 | — | — | — | — |
| VRTX | $130.4B#4 | 30.0x#6 | 6.4x#4 | 10.9x#8 | 8.9%#9 | 838.1%#3 | 34.8%#2 | 19.5%#6 | 25.0%#5 | — | 31.4%#7 | — |
| AMGN | $203.1B#2 | 23.3x#5 | 17.4x#9 | 5.5x#4 | 10.0%#8 | 88.5%#7 | 24.7%#7 | 66.0%#2 | 15.1%#7 | — | 41.1%#5 | 2.5%#1 |
| GILD | $181.4B#3 | — | 15.3x#7 | 6.2x#5 | 2.4%#10 | 1672.9%#2 | 34.0%#3 | 71.9%#1 | 26.7%#4 | — | 34.9%#6 | 2.2%#2 |
| REGN | — | 19.1x#2 | — | — | 1.0%#12 | 2.1%#11 | 24.9%#6 | 14.2%#7 | 9.4%#9 | — | — | — |
| ARGX | $60.6B#5 | — | — | 1705.6x#13 | 254.4%#1 | 55.1%#8 | 2965.7%#1 | — | — | — | 30.5%#8 | — |
| ALNY | $31.9B#11 | 41.5x#8 | 23.5x#10 | 8.6x#7 | 65.2%#3 | 212.8%#4 | 13.5%#10 | 23.2%#4 | 150.5%#1 | — | -48.3%#11 | — |
| NTRA | $50.6B#7 | — | 27.8x#11 | 21.9x#9 | 35.9%#5 | -9.3%#12 | -13.4%#12 | -11.4%#11 | -18.0%#10 | — | 100.5%#3 | — |
| RVMD | $43.9B#8 | — | 16.9x#8 | — | — | -88.5%#15 | — | -43.4%#13 | — | — | 358.6%#1 | — |
| BIIB | $31.9B#10 | 23.2x#4 | 2.2x#1 | 3.2x#1 | 2.2%#11 | -20.8%#13 | 28.7%#5 | 8.7%#9 | 13.0%#8 | 4#3 | 50.4%#4 | — |
| ILMN | $33.6B#9 | 41.5x#7 | 11.8x#6 | 7.7x#6 | -0.7%#13 | 169.5%#5 | 18.6%#9 | 30.0%#3 | 22.0%#6 | 7#1 | 119.0%#2 | — |
| MRNA | $57.4B#6 | — | 8.5x#5 | 29.5x#10 | -39.9%#14 | 20.8%#10 | -158.1%#13 | -41.7%#12 | -54.6%#11 | — | — | — |
| INSM | $26.2B#12 | — | 34.6x#12 | 43.2x#11 | 66.7%#2 | -39.7%#14 | -205.6%#14 | -168.6%#14 | -163.0%#12 | 3#4 | -17.1%#10 | — |
| ONC | $511.7B#1 | 805.0x#9 | 98.9x#13 | 95.8x#12 | 40.2%#4 | 144.5%#6 | 8.4%#11 | 5.5%#10 | 29.9%#3 | 6#2 | 5.8%#9 | — |
| INCY | $24.3B#13 | 17.2x#1 | 4.3x#3 | 4.7x#2 | 21.2%#7 | 3846.9%#1 | 29.5%#4 | 22.9%#5 | 49.0%#2 | — | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-09-16。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议